277 related articles for article (PubMed ID: 10643971)
1. Expression of cyclins and cdks throughout murine carcinogenesis.
Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes.
Mouriaux F; Casagrande F; Pillaire MJ; Manenti S; Malecaze F; Darbon JM
Invest Ophthalmol Vis Sci; 1998 May; 39(6):876-84. PubMed ID: 9579467
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
4. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos.
Moore GD; Ayabe T; Kopf GS; Schultz RM
Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036
[TBL] [Abstract][Full Text] [Related]
5. Cytometry of cyclin proteins.
Darzynkiewicz Z; Gong J; Juan G; Ardelt B; Traganos F
Cytometry; 1996 Sep; 25(1):1-13. PubMed ID: 8875049
[TBL] [Abstract][Full Text] [Related]
6. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
[TBL] [Abstract][Full Text] [Related]
7. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
8. Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy.
Poolman RA; Brooks G
J Mol Cell Cardiol; 1998 Oct; 30(10):2121-35. PubMed ID: 9799664
[TBL] [Abstract][Full Text] [Related]
9. Accelerated growth of hepatocytes in association with Up-regulation of cyclin E in transgenic mice expressing the dominant negative form of retinoic acid receptor.
Tsutusmi A; Shiota G; Yamazaki H; Kunisada T; Terada T; Kawasaki H
Biochem Biophys Res Commun; 2000 Nov; 278(1):229-35. PubMed ID: 11071877
[TBL] [Abstract][Full Text] [Related]
10. Expression of cell cycle regulatory factors in differentiating osteoblasts: postproliferative up-regulation of cyclins B and E.
Smith E; Frenkel B; Schlegel R; Giordano A; Lian JB; Stein JL; Stein GS
Cancer Res; 1995 Nov; 55(21):5019-24. PubMed ID: 7585545
[TBL] [Abstract][Full Text] [Related]
11. Control of cell cycle gene expression in bone development and during c-Fos-induced osteosarcoma formation.
Sunters A; McCluskey J; Grigoriadis AE
Dev Genet; 1998; 22(4):386-97. PubMed ID: 9664690
[TBL] [Abstract][Full Text] [Related]
12. The Pezcoller lecture: cancer cell cycles revisited.
Sherr CJ
Cancer Res; 2000 Jul; 60(14):3689-95. PubMed ID: 10919634
[TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
14. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma.
Bahnassy AA; Zekri AR; Loutfy SA; Mohamed WS; Moneim AA; Salem SE; Sheta MM; Omar A; Al-Zawahry H
Exp Mol Pathol; 2011 Oct; 91(2):643-52. PubMed ID: 21801719
[TBL] [Abstract][Full Text] [Related]
15. Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells.
Juan G; Li X; Darzynkiewicz Z
Cancer Res; 1997 Mar; 57(5):803-7. PubMed ID: 9041174
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
[TBL] [Abstract][Full Text] [Related]
17. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
18. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
Hur K; Kim JR; Yoon BI; Lee JK; Choi JH; Oh GT; Kim DY
J Vet Sci; 2000 Dec; 1(2):121-6. PubMed ID: 14614307
[TBL] [Abstract][Full Text] [Related]
20. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
